Tapewire

Nasdaq · USD

IBIO

iBio, Inc.

Export transactions ↓
Tapewire entity
6906
SEC CIK
0001420720
Parsed reports
157

Last 12 months

Inside the activity.

4 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202640
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
February 20, 2019 Filed May 13, 2019 15:26 UTC
Mullaney James P.Chief Financial Officer
GrantStock Option (right to buy) · Derivative 11,250 Not disclosed Strike: $0.93 Not disclosed
Disclosure

SEC source: 0001638599-19-000500 · doc4_6062.xml · derivative · entry 2

Mullaney James P. · CIK 0001702906 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,250

Underlying: Common Stock · 11,250 shares

Expires 2024-02-20

F5 · price: On 2/20/19, the issuer issued new stock options, pursuant to the issuer's option exchange program, in exchange for old stock options, on the basis of three new options in exchange for four old options, for all eligible option holders who elected to participate in the option exchange, including this option grant to the reporting person.

F4 · derivative.exercise_date: Fully vests on first anniversary of grant date.

F3 · balance_after: Reflects number of securities beneficially owned following all transactions reported on this Form 4.

Read SEC document
February 20, 2019 Filed May 13, 2019 15:26 UTC
Mullaney James P.Chief Financial Officer
Disposition to issuerStock Option (right to buy) · Derivative 15,000 Not disclosed Strike: $4.00 Not disclosed
Disclosure

SEC source: 0001638599-19-000500 · doc4_6062.xml · derivative · entry 1

Mullaney James P. · CIK 0001702906 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,250

Underlying: Common Stock · 15,000 shares

Expires 2027-03-01

F2 · price: On 2/20/19, the issuer canceled, pursuant to the issuer's option exchange program, old stock options in exchange for new stock options, on the basis of three new options in exchange for four old options, for all eligible option holders who elected to participate in the option exchange, including the cancelation of this option grant to the reporting person in exchange for new options.

F1 · derivative.exercise_date: Vested in three equal annual instalments on the anniversary of the date of grant.

F3 · balance_after: Reflects number of securities beneficially owned following all transactions reported on this Form 4.

Read SEC document
February 20, 2019 Filed May 31, 2019 20:17 UTC GrantStock Option (right to buy) · Derivative 4,500 Not disclosed Strike: $0.93 Not disclosed
Disclosure

SEC source: 0001638599-19-000575 · doc4_6056.xml · derivative · entry 14

Elliott Arthur Y · CIK 0001506688 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,500

Underlying: Common Stock · 4,500 shares

Expires 2024-02-20

F5 · price: On 2/20/19, the issuer issued new stock options, pursuant to the issuer's option exchange program, in exchange for old stock options, on the basis of three new options in exchange for four old options, for all eligible option holders who elected to participate in the option exchange, including this option grant to the reporting person.

F4 · derivative.exercise_date: Fully vests on first anniversary of grant date.

F3 · balance_after: Reflects number of securities beneficially owned following all transactions reported on this Form 4.

Read SEC document
February 20, 2019 Filed May 31, 2019 20:17 UTC Disposition to issuerStock Option (right to buy) · Derivative 6,000 Not disclosed Strike: $4.00 Not disclosed
Disclosure

SEC source: 0001638599-19-000575 · doc4_6056.xml · derivative · entry 13

Elliott Arthur Y · CIK 0001506688 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,500

Underlying: Common Stock · 6,000 shares

Expires 2027-05-01

F2 · price: On 2/20/19, the issuer canceled, pursuant to the issuer's option exchange program, old stock options in exchange for new stock options, on the basis of three new options in exchange for four old options, for all eligible option holders who elected to participate in the option exchange, including the cancelation of this option grant to the reporting person in exchange for new options.

F1 · derivative.exercise_date: Vested in three equal annual instalments on the anniversary of the date of grant.

F3 · balance_after: Reflects number of securities beneficially owned following all transactions reported on this Form 4.

Read SEC document
February 20, 2019 Filed May 31, 2019 20:17 UTC GrantStock Option (right to buy) · Derivative 7,500 Not disclosed Strike: $0.93 Not disclosed
Disclosure

SEC source: 0001638599-19-000575 · doc4_6056.xml · derivative · entry 12

Elliott Arthur Y · CIK 0001506688 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,500

Underlying: Common Stock · 7,500 shares

Expires 2024-02-20

F5 · price: On 2/20/19, the issuer issued new stock options, pursuant to the issuer's option exchange program, in exchange for old stock options, on the basis of three new options in exchange for four old options, for all eligible option holders who elected to participate in the option exchange, including this option grant to the reporting person.

F4 · derivative.exercise_date: Fully vests on first anniversary of grant date.

F3 · balance_after: Reflects number of securities beneficially owned following all transactions reported on this Form 4.

Read SEC document
February 20, 2019 Filed May 31, 2019 20:17 UTC Disposition to issuerStock Option (right to buy) · Derivative 10,000 Not disclosed Strike: $17.20 Not disclosed
Disclosure

SEC source: 0001638599-19-000575 · doc4_6056.xml · derivative · entry 11

Elliott Arthur Y · CIK 0001506688 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,500

Underlying: Common Stock · 10,000 shares

Expires 2025-09-04

F2 · price: On 2/20/19, the issuer canceled, pursuant to the issuer's option exchange program, old stock options in exchange for new stock options, on the basis of three new options in exchange for four old options, for all eligible option holders who elected to participate in the option exchange, including the cancelation of this option grant to the reporting person in exchange for new options.

F1 · derivative.exercise_date: Vested in three equal annual instalments on the anniversary of the date of grant.

F3 · balance_after: Reflects number of securities beneficially owned following all transactions reported on this Form 4.

Read SEC document
February 20, 2019 Filed May 31, 2019 20:17 UTC GrantStock Option (right to buy) · Derivative 4,500 Not disclosed Strike: $0.93 Not disclosed
Disclosure

SEC source: 0001638599-19-000575 · doc4_6056.xml · derivative · entry 10

Elliott Arthur Y · CIK 0001506688 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,500

Underlying: Common Stock · 4,500 shares

Expires 2024-02-20

F5 · price: On 2/20/19, the issuer issued new stock options, pursuant to the issuer's option exchange program, in exchange for old stock options, on the basis of three new options in exchange for four old options, for all eligible option holders who elected to participate in the option exchange, including this option grant to the reporting person.

F4 · derivative.exercise_date: Fully vests on first anniversary of grant date.

F3 · balance_after: Reflects number of securities beneficially owned following all transactions reported on this Form 4.

Read SEC document
February 20, 2019 Filed May 31, 2019 20:17 UTC Disposition to issuerStock Option (right to buy) · Derivative 6,000 Not disclosed Strike: $4.90 Not disclosed
Disclosure

SEC source: 0001638599-19-000575 · doc4_6056.xml · derivative · entry 9

Elliott Arthur Y · CIK 0001506688 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,500

Underlying: Common Stock · 6,000 shares

Expires 2024-09-05

F2 · price: On 2/20/19, the issuer canceled, pursuant to the issuer's option exchange program, old stock options in exchange for new stock options, on the basis of three new options in exchange for four old options, for all eligible option holders who elected to participate in the option exchange, including the cancelation of this option grant to the reporting person in exchange for new options.

F1 · derivative.exercise_date: Vested in three equal annual instalments on the anniversary of the date of grant.

F3 · balance_after: Reflects number of securities beneficially owned following all transactions reported on this Form 4.

Read SEC document
February 20, 2019 Filed May 31, 2019 20:17 UTC GrantStock Option (right to buy) · Derivative 4,500 Not disclosed Strike: $0.93 Not disclosed
Disclosure

SEC source: 0001638599-19-000575 · doc4_6056.xml · derivative · entry 8

Elliott Arthur Y · CIK 0001506688 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,500

Underlying: Common Stock · 4,500 shares

Expires 2024-02-20

F5 · price: On 2/20/19, the issuer issued new stock options, pursuant to the issuer's option exchange program, in exchange for old stock options, on the basis of three new options in exchange for four old options, for all eligible option holders who elected to participate in the option exchange, including this option grant to the reporting person.

F4 · derivative.exercise_date: Fully vests on first anniversary of grant date.

F3 · balance_after: Reflects number of securities beneficially owned following all transactions reported on this Form 4.

Read SEC document
February 20, 2019 Filed May 31, 2019 20:17 UTC Disposition to issuerStock Option (right to buy) · Derivative 6,000 Not disclosed Strike: $5.00 Not disclosed
Disclosure

SEC source: 0001638599-19-000575 · doc4_6056.xml · derivative · entry 7

Elliott Arthur Y · CIK 0001506688 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,500

Underlying: Common Stock · 6,000 shares

Expires 2023-07-16

F2 · price: On 2/20/19, the issuer canceled, pursuant to the issuer's option exchange program, old stock options in exchange for new stock options, on the basis of three new options in exchange for four old options, for all eligible option holders who elected to participate in the option exchange, including the cancelation of this option grant to the reporting person in exchange for new options.

F1 · derivative.exercise_date: Vested in three equal annual instalments on the anniversary of the date of grant.

F3 · balance_after: Reflects number of securities beneficially owned following all transactions reported on this Form 4.

Read SEC document
February 20, 2019 Filed May 31, 2019 20:17 UTC GrantStock Option (right to buy) · Derivative 4,500 Not disclosed Strike: $0.93 Not disclosed
Disclosure

SEC source: 0001638599-19-000575 · doc4_6056.xml · derivative · entry 6

Elliott Arthur Y · CIK 0001506688 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,500

Underlying: Common Stock · 4,500 shares

Expires 2024-02-20

F5 · price: On 2/20/19, the issuer issued new stock options, pursuant to the issuer's option exchange program, in exchange for old stock options, on the basis of three new options in exchange for four old options, for all eligible option holders who elected to participate in the option exchange, including this option grant to the reporting person.

F4 · derivative.exercise_date: Fully vests on first anniversary of grant date.

F3 · balance_after: Reflects number of securities beneficially owned following all transactions reported on this Form 4.

Read SEC document
February 20, 2019 Filed May 31, 2019 20:17 UTC Disposition to issuerStock Option (right to buy) · Derivative 6,000 Not disclosed Strike: $11.00 Not disclosed
Disclosure

SEC source: 0001638599-19-000575 · doc4_6056.xml · derivative · entry 5

Elliott Arthur Y · CIK 0001506688 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,500

Underlying: Common Stock · 6,000 shares

Expires 2022-07-24

F2 · price: On 2/20/19, the issuer canceled, pursuant to the issuer's option exchange program, old stock options in exchange for new stock options, on the basis of three new options in exchange for four old options, for all eligible option holders who elected to participate in the option exchange, including the cancelation of this option grant to the reporting person in exchange for new options.

F1 · derivative.exercise_date: Vested in three equal annual instalments on the anniversary of the date of grant.

F3 · balance_after: Reflects number of securities beneficially owned following all transactions reported on this Form 4.

Read SEC document
February 20, 2019 Filed May 31, 2019 20:17 UTC GrantStock Option (right to buy) · Derivative 4,500 Not disclosed Strike: $0.93 Not disclosed
Disclosure

SEC source: 0001638599-19-000575 · doc4_6056.xml · derivative · entry 4

Elliott Arthur Y · CIK 0001506688 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,500

Underlying: Common Stock · 4,500 shares

Expires 2024-02-20

F5 · price: On 2/20/19, the issuer issued new stock options, pursuant to the issuer's option exchange program, in exchange for old stock options, on the basis of three new options in exchange for four old options, for all eligible option holders who elected to participate in the option exchange, including this option grant to the reporting person.

F4 · derivative.exercise_date: Fully vests on first anniversary of grant date.

F3 · balance_after: Reflects number of securities beneficially owned following all transactions reported on this Form 4.

Read SEC document
February 20, 2019 Filed May 31, 2019 20:17 UTC Disposition to issuerStock Option (right to buy) · Derivative 6,000 Not disclosed Strike: $19.60 Not disclosed
Disclosure

SEC source: 0001638599-19-000575 · doc4_6056.xml · derivative · entry 3

Elliott Arthur Y · CIK 0001506688 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,500

Underlying: Common Stock · 6,000 shares

Expires 2021-10-21

F2 · price: On 2/20/19, the issuer canceled, pursuant to the issuer's option exchange program, old stock options in exchange for new stock options, on the basis of three new options in exchange for four old options, for all eligible option holders who elected to participate in the option exchange, including the cancelation of this option grant to the reporting person in exchange for new options.

F1 · derivative.exercise_date: Vested in three equal annual instalments on the anniversary of the date of grant.

F3 · balance_after: Reflects number of securities beneficially owned following all transactions reported on this Form 4.

Read SEC document
February 20, 2019 Filed May 31, 2019 20:17 UTC GrantStock Option (right to buy) · Derivative 4,500 Not disclosed Strike: $0.93 Not disclosed
Disclosure

SEC source: 0001638599-19-000575 · doc4_6056.xml · derivative · entry 2

Elliott Arthur Y · CIK 0001506688 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,500

Underlying: Common Stock · 4,500 shares

Expires 2024-02-20

F5 · price: On 2/20/19, the issuer issued new stock options, pursuant to the issuer's option exchange program, in exchange for old stock options, on the basis of three new options in exchange for four old options, for all eligible option holders who elected to participate in the option exchange, including this option grant to the reporting person.

F4 · derivative.exercise_date: Fully vests on first anniversary of grant date.

F3 · balance_after: Reflects number of securities beneficially owned following all transactions reported on this Form 4.

Read SEC document
February 20, 2019 Filed May 31, 2019 20:17 UTC Disposition to issuerStock Option (right to buy) · Derivative 6,000 Not disclosed Strike: $14.00 Not disclosed
Disclosure

SEC source: 0001638599-19-000575 · doc4_6056.xml · derivative · entry 1

Elliott Arthur Y · CIK 0001506688 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,500

Underlying: Common Stock · 6,000 shares

Expires 2020-07-10

F2 · price: On 2/20/19, the issuer canceled, pursuant to the issuer's option exchange program, old stock options in exchange for new stock options, on the basis of three new options in exchange for four old options, for all eligible option holders who elected to participate in the option exchange, including the cancelation of this option grant to the reporting person in exchange for new options.

F1 · derivative.exercise_date: Vested in three equal annual instalments on the anniversary of the date of grant.

F3 · balance_after: Reflects number of securities beneficially owned following all transactions reported on this Form 4.

Read SEC document
February 20, 2019 Filed May 31, 2019 20:16 UTC Amendment
Kay RobertDirector · Executive Chairman and CEO
GrantStock Option (right to buy) · Derivative 22,500 Not disclosed Strike: $0.93 Not disclosed
Disclosure

SEC source: 0001638599-19-000574 · doc4a_6128.xml · derivative · entry 20

Kay Robert · CIK 0001285612 · Director · Executive Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 307,500

Underlying: Common Stock · 22,500 shares

Expires 2024-02-20

F5 · price: On 2/20/19, the issuer issued new stock options, pursuant to the issuer's option exchange program, in exchange for old stock options, on the basis of three new options in exchange for four old options, for all eligible option holders who elected to participate in the option exchange, including this option grant to the reporting person.

F4 · derivative.exercise_date: Fully vests on first anniversary of grant date.

F3 · balance_after: Reflects number of securities beneficially owned following all transactions reported on this Form 4/A.

F8 · balance_after: This report on Form 4/A corrects an error with respect to the Amount of Securities Beneficially Owned Following Reported Transaction.

Read SEC document
February 20, 2019 Filed May 31, 2019 20:16 UTC Amendment
Kay RobertDirector · Executive Chairman and CEO
Disposition to issuerStock Option (right to buy) · Derivative 30,000 Not disclosed Strike: $4.00 Not disclosed
Disclosure

SEC source: 0001638599-19-000574 · doc4a_6128.xml · derivative · entry 19

Kay Robert · CIK 0001285612 · Director · Executive Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 307,500

Underlying: Common Stock · 30,000 shares

Expires 2027-05-01

F2 · price: On 2/20/19, the issuer canceled, pursuant to the issuer's option exchange program, old stock options in exchange for new stock options, on the basis of three new options in exchange for four old options, for all eligible option holders who elected to participate in the option exchange, including the cancelation of this option grant to the reporting person in exchange for new options.

F7 · derivative.exercise_date: Vested in three equal annual instalments on the anniversary of the date of grant.

F3 · balance_after: Reflects number of securities beneficially owned following all transactions reported on this Form 4/A.

F8 · balance_after: This report on Form 4/A corrects an error with respect to the Amount of Securities Beneficially Owned Following Reported Transaction.

Read SEC document
February 20, 2019 Filed May 31, 2019 20:16 UTC Amendment
Kay RobertDirector · Executive Chairman and CEO
GrantStock Option (right to buy) · Derivative 56,250 Not disclosed Strike: $0.93 Not disclosed
Disclosure

SEC source: 0001638599-19-000574 · doc4a_6128.xml · derivative · entry 18

Kay Robert · CIK 0001285612 · Director · Executive Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 307,500

Underlying: Common Stock · 56,250 shares

Expires 2024-02-20

F5 · price: On 2/20/19, the issuer issued new stock options, pursuant to the issuer's option exchange program, in exchange for old stock options, on the basis of three new options in exchange for four old options, for all eligible option holders who elected to participate in the option exchange, including this option grant to the reporting person.

F4 · derivative.exercise_date: Fully vests on first anniversary of grant date.

F3 · balance_after: Reflects number of securities beneficially owned following all transactions reported on this Form 4/A.

F8 · balance_after: This report on Form 4/A corrects an error with respect to the Amount of Securities Beneficially Owned Following Reported Transaction.

Read SEC document
February 20, 2019 Filed May 31, 2019 20:16 UTC Amendment
Kay RobertDirector · Executive Chairman and CEO
Disposition to issuerStock Option (right to buy) · Derivative 75,000 Not disclosed Strike: $17.20 Not disclosed
Disclosure

SEC source: 0001638599-19-000574 · doc4a_6128.xml · derivative · entry 17

Kay Robert · CIK 0001285612 · Director · Executive Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 307,500

Underlying: Common Stock · 75,000 shares

Expires 2025-09-04

F2 · price: On 2/20/19, the issuer canceled, pursuant to the issuer's option exchange program, old stock options in exchange for new stock options, on the basis of three new options in exchange for four old options, for all eligible option holders who elected to participate in the option exchange, including the cancelation of this option grant to the reporting person in exchange for new options.

F7 · derivative.exercise_date: Vested in three equal annual instalments on the anniversary of the date of grant.

F3 · balance_after: Reflects number of securities beneficially owned following all transactions reported on this Form 4/A.

F8 · balance_after: This report on Form 4/A corrects an error with respect to the Amount of Securities Beneficially Owned Following Reported Transaction.

Read SEC document
February 20, 2019 Filed May 31, 2019 20:16 UTC Amendment
Kay RobertDirector · Executive Chairman and CEO
GrantStock Option (right to buy) · Derivative 45,000 Not disclosed Strike: $0.93 Not disclosed
Disclosure

SEC source: 0001638599-19-000574 · doc4a_6128.xml · derivative · entry 16

Kay Robert · CIK 0001285612 · Director · Executive Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 307,500

Underlying: Common Stock · 45,000 shares

Expires 2024-02-20

F5 · price: On 2/20/19, the issuer issued new stock options, pursuant to the issuer's option exchange program, in exchange for old stock options, on the basis of three new options in exchange for four old options, for all eligible option holders who elected to participate in the option exchange, including this option grant to the reporting person.

F4 · derivative.exercise_date: Fully vests on first anniversary of grant date.

F3 · balance_after: Reflects number of securities beneficially owned following all transactions reported on this Form 4/A.

F8 · balance_after: This report on Form 4/A corrects an error with respect to the Amount of Securities Beneficially Owned Following Reported Transaction.

Read SEC document
February 20, 2019 Filed May 31, 2019 20:16 UTC Amendment
Kay RobertDirector · Executive Chairman and CEO
Disposition to issuerStock Option (right to buy) · Derivative 60,000 Not disclosed Strike: $10.00 Not disclosed
Disclosure

SEC source: 0001638599-19-000574 · doc4a_6128.xml · derivative · entry 15

Kay Robert · CIK 0001285612 · Director · Executive Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 307,500

Underlying: Common Stock · 60,000 shares

Expires 2024-09-05

F2 · price: On 2/20/19, the issuer canceled, pursuant to the issuer's option exchange program, old stock options in exchange for new stock options, on the basis of three new options in exchange for four old options, for all eligible option holders who elected to participate in the option exchange, including the cancelation of this option grant to the reporting person in exchange for new options.

F7 · derivative.exercise_date: Vested in three equal annual instalments on the anniversary of the date of grant.

F3 · balance_after: Reflects number of securities beneficially owned following all transactions reported on this Form 4/A.

F8 · balance_after: This report on Form 4/A corrects an error with respect to the Amount of Securities Beneficially Owned Following Reported Transaction.

Read SEC document
February 20, 2019 Filed May 31, 2019 20:16 UTC Amendment
Kay RobertDirector · Executive Chairman and CEO
GrantStock Option (right to buy) · Derivative 22,500 Not disclosed Strike: $0.93 Not disclosed
Disclosure

SEC source: 0001638599-19-000574 · doc4a_6128.xml · derivative · entry 14

Kay Robert · CIK 0001285612 · Director · Executive Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 307,500

Underlying: Common Stock · 22,500 shares

Expires 2024-02-20

F5 · price: On 2/20/19, the issuer issued new stock options, pursuant to the issuer's option exchange program, in exchange for old stock options, on the basis of three new options in exchange for four old options, for all eligible option holders who elected to participate in the option exchange, including this option grant to the reporting person.

F4 · derivative.exercise_date: Fully vests on first anniversary of grant date.

F3 · balance_after: Reflects number of securities beneficially owned following all transactions reported on this Form 4/A.

F8 · balance_after: This report on Form 4/A corrects an error with respect to the Amount of Securities Beneficially Owned Following Reported Transaction.

Read SEC document
February 20, 2019 Filed May 31, 2019 20:16 UTC Amendment
Kay RobertDirector · Executive Chairman and CEO
Disposition to issuerStock Option (right to buy) · Derivative 30,000 Not disclosed Strike: $5.00 Not disclosed
Disclosure

SEC source: 0001638599-19-000574 · doc4a_6128.xml · derivative · entry 13

Kay Robert · CIK 0001285612 · Director · Executive Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 307,500

Underlying: Common Stock · 30,000 shares

Expires 2023-07-16

F2 · price: On 2/20/19, the issuer canceled, pursuant to the issuer's option exchange program, old stock options in exchange for new stock options, on the basis of three new options in exchange for four old options, for all eligible option holders who elected to participate in the option exchange, including the cancelation of this option grant to the reporting person in exchange for new options.

F1 · derivative.exercise_date: Vested in five annual instalments on anniversaries of date of grant.

F3 · balance_after: Reflects number of securities beneficially owned following all transactions reported on this Form 4/A.

F8 · balance_after: This report on Form 4/A corrects an error with respect to the Amount of Securities Beneficially Owned Following Reported Transaction.

Read SEC document
February 20, 2019 Filed May 31, 2019 20:16 UTC Amendment
Kay RobertDirector · Executive Chairman and CEO
GrantStock Option (right to buy) · Derivative 22,500 Not disclosed Strike: $0.93 Not disclosed
Disclosure

SEC source: 0001638599-19-000574 · doc4a_6128.xml · derivative · entry 12

Kay Robert · CIK 0001285612 · Director · Executive Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 307,500

Underlying: Common Stock · 22,500 shares

Expires 2024-02-20

F5 · price: On 2/20/19, the issuer issued new stock options, pursuant to the issuer's option exchange program, in exchange for old stock options, on the basis of three new options in exchange for four old options, for all eligible option holders who elected to participate in the option exchange, including this option grant to the reporting person.

F4 · derivative.exercise_date: Fully vests on first anniversary of grant date.

F3 · balance_after: Reflects number of securities beneficially owned following all transactions reported on this Form 4/A.

F8 · balance_after: This report on Form 4/A corrects an error with respect to the Amount of Securities Beneficially Owned Following Reported Transaction.

Read SEC document
February 20, 2019 Filed May 31, 2019 20:16 UTC Amendment
Kay RobertDirector · Executive Chairman and CEO
Disposition to issuerStock Option (right to buy) · Derivative 30,000 Not disclosed Strike: $11.00 Not disclosed
Disclosure

SEC source: 0001638599-19-000574 · doc4a_6128.xml · derivative · entry 11

Kay Robert · CIK 0001285612 · Director · Executive Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 307,500

Underlying: Common Stock · 30,000 shares

Expires 2022-07-24

F2 · price: On 2/20/19, the issuer canceled, pursuant to the issuer's option exchange program, old stock options in exchange for new stock options, on the basis of three new options in exchange for four old options, for all eligible option holders who elected to participate in the option exchange, including the cancelation of this option grant to the reporting person in exchange for new options.

F1 · derivative.exercise_date: Vested in five annual instalments on anniversaries of date of grant.

F3 · balance_after: Reflects number of securities beneficially owned following all transactions reported on this Form 4/A.

F8 · balance_after: This report on Form 4/A corrects an error with respect to the Amount of Securities Beneficially Owned Following Reported Transaction.

Read SEC document
February 20, 2019 Filed May 31, 2019 20:16 UTC Amendment
Kay RobertDirector · Executive Chairman and CEO
GrantStock Option (right to buy) · Derivative 22,500 Not disclosed Strike: $0.93 Not disclosed
Disclosure

SEC source: 0001638599-19-000574 · doc4a_6128.xml · derivative · entry 10

Kay Robert · CIK 0001285612 · Director · Executive Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 307,500

Underlying: Common Stock · 22,500 shares

Expires 2024-02-20

F5 · price: On 2/20/19, the issuer issued new stock options, pursuant to the issuer's option exchange program, in exchange for old stock options, on the basis of three new options in exchange for four old options, for all eligible option holders who elected to participate in the option exchange, including this option grant to the reporting person.

F4 · derivative.exercise_date: Fully vests on first anniversary of grant date.

F3 · balance_after: Reflects number of securities beneficially owned following all transactions reported on this Form 4/A.

F8 · balance_after: This report on Form 4/A corrects an error with respect to the Amount of Securities Beneficially Owned Following Reported Transaction.

Read SEC document
February 20, 2019 Filed May 31, 2019 20:16 UTC Amendment
Kay RobertDirector · Executive Chairman and CEO
Disposition to issuerStock Option (right to buy) · Derivative 30,000 Not disclosed Strike: $19.60 Not disclosed
Disclosure

SEC source: 0001638599-19-000574 · doc4a_6128.xml · derivative · entry 9

Kay Robert · CIK 0001285612 · Director · Executive Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 307,500

Underlying: Common Stock · 30,000 shares

Expires 2021-10-21

F2 · price: On 2/20/19, the issuer canceled, pursuant to the issuer's option exchange program, old stock options in exchange for new stock options, on the basis of three new options in exchange for four old options, for all eligible option holders who elected to participate in the option exchange, including the cancelation of this option grant to the reporting person in exchange for new options.

F1 · derivative.exercise_date: Vested in five annual instalments on anniversaries of date of grant.

F3 · balance_after: Reflects number of securities beneficially owned following all transactions reported on this Form 4/A.

F8 · balance_after: This report on Form 4/A corrects an error with respect to the Amount of Securities Beneficially Owned Following Reported Transaction.

Read SEC document
February 20, 2019 Filed May 31, 2019 20:16 UTC Amendment
Kay RobertDirector · Executive Chairman and CEO
GrantStock Option (right to buy) · Derivative 37,500 Not disclosed Strike: $0.93 Not disclosed
Disclosure

SEC source: 0001638599-19-000574 · doc4a_6128.xml · derivative · entry 8

Kay Robert · CIK 0001285612 · Director · Executive Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 307,500

Underlying: Common Stock · 37,500 shares

Expires 2024-02-20

F5 · price: On 2/20/19, the issuer issued new stock options, pursuant to the issuer's option exchange program, in exchange for old stock options, on the basis of three new options in exchange for four old options, for all eligible option holders who elected to participate in the option exchange, including this option grant to the reporting person.

F4 · derivative.exercise_date: Fully vests on first anniversary of grant date.

F3 · balance_after: Reflects number of securities beneficially owned following all transactions reported on this Form 4/A.

F8 · balance_after: This report on Form 4/A corrects an error with respect to the Amount of Securities Beneficially Owned Following Reported Transaction.

Read SEC document
February 20, 2019 Filed May 31, 2019 20:16 UTC Amendment
Kay RobertDirector · Executive Chairman and CEO
Disposition to issuerStock Option (right to buy) · Derivative 50,000 Not disclosed Strike: $30.70 Not disclosed
Disclosure

SEC source: 0001638599-19-000574 · doc4a_6128.xml · derivative · entry 7

Kay Robert · CIK 0001285612 · Director · Executive Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 307,500

Underlying: Common Stock · 50,000 shares

Expires 2020-12-30

F2 · price: On 2/20/19, the issuer canceled, pursuant to the issuer's option exchange program, old stock options in exchange for new stock options, on the basis of three new options in exchange for four old options, for all eligible option holders who elected to participate in the option exchange, including the cancelation of this option grant to the reporting person in exchange for new options.

F7 · derivative.exercise_date: Vested in three equal annual instalments on the anniversary of the date of grant.

F3 · balance_after: Reflects number of securities beneficially owned following all transactions reported on this Form 4/A.

F8 · balance_after: This report on Form 4/A corrects an error with respect to the Amount of Securities Beneficially Owned Following Reported Transaction.

Read SEC document
February 20, 2019 Filed May 31, 2019 20:16 UTC Amendment
Kay RobertDirector · Executive Chairman and CEO
GrantStock Option (right to buy) · Derivative 37,500 Not disclosed Strike: $0.93 Not disclosed
Disclosure

SEC source: 0001638599-19-000574 · doc4a_6128.xml · derivative · entry 6

Kay Robert · CIK 0001285612 · Director · Executive Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 307,500

Underlying: Common Stock · 37,500 shares

Expires 2024-02-20

F5 · price: On 2/20/19, the issuer issued new stock options, pursuant to the issuer's option exchange program, in exchange for old stock options, on the basis of three new options in exchange for four old options, for all eligible option holders who elected to participate in the option exchange, including this option grant to the reporting person.

F4 · derivative.exercise_date: Fully vests on first anniversary of grant date.

F3 · balance_after: Reflects number of securities beneficially owned following all transactions reported on this Form 4/A.

F8 · balance_after: This report on Form 4/A corrects an error with respect to the Amount of Securities Beneficially Owned Following Reported Transaction.

Read SEC document
February 20, 2019 Filed May 31, 2019 20:16 UTC Amendment
Kay RobertDirector · Executive Chairman and CEO
Disposition to issuerStock Option (right to buy) · Derivative 50,000 Not disclosed Strike: $30.70 Not disclosed
Disclosure

SEC source: 0001638599-19-000574 · doc4a_6128.xml · derivative · entry 5

Kay Robert · CIK 0001285612 · Director · Executive Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 307,500

Underlying: Common Stock · 50,000 shares

Expires 2020-12-30

F2 · price: On 2/20/19, the issuer canceled, pursuant to the issuer's option exchange program, old stock options in exchange for new stock options, on the basis of three new options in exchange for four old options, for all eligible option holders who elected to participate in the option exchange, including the cancelation of this option grant to the reporting person in exchange for new options.

F7 · derivative.exercise_date: Vested in three equal annual instalments on the anniversary of the date of grant.

F3 · balance_after: Reflects number of securities beneficially owned following all transactions reported on this Form 4/A.

F8 · balance_after: This report on Form 4/A corrects an error with respect to the Amount of Securities Beneficially Owned Following Reported Transaction.

Read SEC document
February 20, 2019 Filed May 31, 2019 20:16 UTC Amendment
Kay RobertDirector · Executive Chairman and CEO
GrantStock Option (right to buy) · Derivative 22,500 Not disclosed Strike: $0.93 Not disclosed
Disclosure

SEC source: 0001638599-19-000574 · doc4a_6128.xml · derivative · entry 4

Kay Robert · CIK 0001285612 · Director · Executive Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 307,500

Underlying: Common Stock · 22,500 shares

Expires 2024-02-20

F5 · price: On 2/20/19, the issuer issued new stock options, pursuant to the issuer's option exchange program, in exchange for old stock options, on the basis of three new options in exchange for four old options, for all eligible option holders who elected to participate in the option exchange, including this option grant to the reporting person.

F4 · derivative.exercise_date: Fully vests on first anniversary of grant date.

F3 · balance_after: Reflects number of securities beneficially owned following all transactions reported on this Form 4/A.

F8 · balance_after: This report on Form 4/A corrects an error with respect to the Amount of Securities Beneficially Owned Following Reported Transaction.

Read SEC document
February 20, 2019 Filed May 31, 2019 20:16 UTC Amendment
Kay RobertDirector · Executive Chairman and CEO
Disposition to issuerStock Option (right to buy) · Derivative 30,000 Not disclosed Strike: $17.30 Not disclosed
Disclosure

SEC source: 0001638599-19-000574 · doc4a_6128.xml · derivative · entry 3

Kay Robert · CIK 0001285612 · Director · Executive Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 307,500

Underlying: Common Stock · 30,000 shares

Expires 2020-08-16

F2 · price: On 2/20/19, the issuer canceled, pursuant to the issuer's option exchange program, old stock options in exchange for new stock options, on the basis of three new options in exchange for four old options, for all eligible option holders who elected to participate in the option exchange, including the cancelation of this option grant to the reporting person in exchange for new options.

F6 · derivative.exercise_date: Vested 20% on 7/1/2010 and then in 20% instalments on each anniversary thereof.

F3 · balance_after: Reflects number of securities beneficially owned following all transactions reported on this Form 4/A.

F8 · balance_after: This report on Form 4/A corrects an error with respect to the Amount of Securities Beneficially Owned Following Reported Transaction.

Read SEC document
February 20, 2019 Filed May 31, 2019 20:16 UTC Amendment
Kay RobertDirector · Executive Chairman and CEO
GrantStock Option (right to buy) · Derivative 18,750 Not disclosed Strike: $0.93 Not disclosed
Disclosure

SEC source: 0001638599-19-000574 · doc4a_6128.xml · derivative · entry 2

Kay Robert · CIK 0001285612 · Director · Executive Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 307,500

Underlying: Common Stock · 18,750 shares

Expires 2024-02-20

F5 · price: On 2/20/19, the issuer issued new stock options, pursuant to the issuer's option exchange program, in exchange for old stock options, on the basis of three new options in exchange for four old options, for all eligible option holders who elected to participate in the option exchange, including this option grant to the reporting person.

F4 · derivative.exercise_date: Fully vests on first anniversary of grant date.

F3 · balance_after: Reflects number of securities beneficially owned following all transactions reported on this Form 4/A.

F8 · balance_after: This report on Form 4/A corrects an error with respect to the Amount of Securities Beneficially Owned Following Reported Transaction.

Read SEC document
February 20, 2019 Filed May 31, 2019 20:16 UTC Amendment
Kay RobertDirector · Executive Chairman and CEO
Disposition to issuerStock Option (right to buy) · Derivative 25,000 Not disclosed Strike: $6.60 Not disclosed
Disclosure

SEC source: 0001638599-19-000574 · doc4a_6128.xml · derivative · entry 1

Kay Robert · CIK 0001285612 · Director · Executive Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 307,500

Underlying: Common Stock · 25,000 shares

Expires 2019-08-10

F2 · price: On 2/20/19, the issuer canceled, pursuant to the issuer's option exchange program, old stock options in exchange for new stock options, on the basis of three new options in exchange for four old options, for all eligible option holders who elected to participate in the option exchange, including the cancelation of this option grant to the reporting person in exchange for new options.

F1 · derivative.exercise_date: Vested in five annual instalments on anniversaries of date of grant.

F3 · balance_after: Reflects number of securities beneficially owned following all transactions reported on this Form 4/A.

F8 · balance_after: This report on Form 4/A corrects an error with respect to the Amount of Securities Beneficially Owned Following Reported Transaction.

Read SEC document
January 01, 2019 Filed Jan 3, 2019 19:42 UTC OtherPreferred Stock 1 Not disclosed Not disclosed
Disclosure

SEC source: 0001408408-19-000007 · ownership.xml · nonDerivative · entry 1

DART KENNETH BRYAN · CIK 0001331271 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By Company

Disclosed balance after: 1

F1 · security: As of January 1, 2019, the Reporting Person indirectly owns 70.1% of an entity that holds one share of the Issuer's Preferred Stock designated as iBio CMO Preferred Tracking Stock with a par value of $0.001 per share (the "Preferred Tracking Stock").

F1 · shares: As of January 1, 2019, the Reporting Person indirectly owns 70.1% of an entity that holds one share of the Issuer's Preferred Stock designated as iBio CMO Preferred Tracking Stock with a par value of $0.001 per share (the "Preferred Tracking Stock").

F1 · price: As of January 1, 2019, the Reporting Person indirectly owns 70.1% of an entity that holds one share of the Issuer's Preferred Stock designated as iBio CMO Preferred Tracking Stock with a par value of $0.001 per share (the "Preferred Tracking Stock").

F1 · balance_after: As of January 1, 2019, the Reporting Person indirectly owns 70.1% of an entity that holds one share of the Issuer's Preferred Stock designated as iBio CMO Preferred Tracking Stock with a par value of $0.001 per share (the "Preferred Tracking Stock").

Read SEC document
July 12, 2018 Filed Jul 13, 2018 16:06 UTC PurchaseCommon Shares 2,200,000 $0.90 $1,980,000.00
Disclosure

SEC source: 0001408408-18-000018 · ecl_ibioform407112018.xml · nonDerivative · entry 1

Eastern Capital LTD · CIK 0001408408 · 10% owner

Portfolio Services Ltd. · CIK 0001488856 · 10% owner

DART KENNETH BRYAN · CIK 0001331271 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,457,734

F1 · security: Eastern Capital Limited acquired 2,200,000 shares of common stock of the Issuer at a price of $0.90 per share as part of an underwritten public offering.

Read SEC document
June 26, 2018 Filed Jun 28, 2018 18:03 UTC PurchaseSeries B Preferred Shares · Derivative 5,785 $1,000.00 $5,785,000.00
Disclosure

SEC source: 0001408408-18-000014 · ecl_ibioform406282018.xml · derivative · entry 2

Eastern Capital LTD · CIK 0001408408 · 10% owner

Portfolio Services Ltd. · CIK 0001488856 · 10% owner

DART KENNETH BRYAN · CIK 0001331271 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,785

Underlying: Common Stock · 6,427,778 shares

Expires not disclosed

F2 · security: The Series B Preferred Shares is convertible into Shares at the option of Eastern Capital Limited, at any time, at a conversion price equal to the public offering price of the Shares, and are subject to a limit of exercise to the extent (and only to the extent) that Eastern Capital Limited or any of its affiliates would beneficially own in excess of 48% of the Shares after giving effect to such exercise.

F2 · derivative.exercise_price: The Series B Preferred Shares is convertible into Shares at the option of Eastern Capital Limited, at any time, at a conversion price equal to the public offering price of the Shares, and are subject to a limit of exercise to the extent (and only to the extent) that Eastern Capital Limited or any of its affiliates would beneficially own in excess of 48% of the Shares after giving effect to such exercise.

F1 · shares: Eastern Capital Limited acquired 1,683,334 shares of Common Stock of the Issuer (the "Shares") at a price of $0.90 per share and 5,785 Series B Preferred Shares at an offering price of $1,000 per Series B Preferred Share on June 26, 2018, in an underwritten public offering.

F2 · derivative.exercise_date: The Series B Preferred Shares is convertible into Shares at the option of Eastern Capital Limited, at any time, at a conversion price equal to the public offering price of the Shares, and are subject to a limit of exercise to the extent (and only to the extent) that Eastern Capital Limited or any of its affiliates would beneficially own in excess of 48% of the Shares after giving effect to such exercise.

F2 · derivative.expiration_date: The Series B Preferred Shares is convertible into Shares at the option of Eastern Capital Limited, at any time, at a conversion price equal to the public offering price of the Shares, and are subject to a limit of exercise to the extent (and only to the extent) that Eastern Capital Limited or any of its affiliates would beneficially own in excess of 48% of the Shares after giving effect to such exercise.

Read SEC document
June 26, 2018 Filed Jun 28, 2018 18:03 UTC PurchaseCommon Shares 1,683,334 $0.90 $1,515,000.60
Disclosure

SEC source: 0001408408-18-000014 · ecl_ibioform406282018.xml · nonDerivative · entry 1

Eastern Capital LTD · CIK 0001408408 · 10% owner

Portfolio Services Ltd. · CIK 0001488856 · 10% owner

DART KENNETH BRYAN · CIK 0001331271 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,257,734

F1 · security: Eastern Capital Limited acquired 1,683,334 shares of Common Stock of the Issuer (the "Shares") at a price of $0.90 per share and 5,785 Series B Preferred Shares at an offering price of $1,000 per Series B Preferred Share on June 26, 2018, in an underwritten public offering.

Read SEC document
November 30, 2017 Filed Dec 4, 2017 17:14 UTC PurchaseCommon Stock 12,000,000 $0.20 $2,400,000.00
Disclosure

SEC source: 0001408408-17-000036 · ecl-ibiof412042017.xml · nonDerivative · entry 1

Eastern Capital LTD · CIK 0001408408 · 10% owner

Portfolio Services Ltd. · CIK 0001488856 · 10% owner

DART KENNETH BRYAN · CIK 0001331271 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 45,744,000

Read SEC document
May 01, 2017 Filed Jun 16, 2017 10:43 UTC GrantStock Option (right to buy) · Derivative 60,000 $0.40 Strike: $0.40 $24,000.00
Disclosure

SEC source: 0001638599-17-000600 · doc4_4796.xml · derivative · entry 1

MCKEY JOHN D JR · CIK 0001120452 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 650,000

Underlying: Common Stock · 60,000 shares

Expires 2027-05-01

F1 · derivative.exercise_date: Vests in equal annual installments over three years beginning 12/1/16.

Read SEC document
May 01, 2017 Filed Jun 16, 2017 10:48 UTC GrantStock Option (right to buy) · Derivative 60,000 $0.40 Strike: $0.40 $24,000.00
Disclosure

SEC source: 0001638599-17-000602 · doc4_4797.xml · derivative · entry 1

RUSSELL PHILIP K. · CIK 0001486819 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 460,000

Underlying: Common Stock · 60,000 shares

Expires 2027-05-01

F1 · derivative.exercise_date: Vests in equal annual installments over three years beginning 12/1/16.

Read SEC document
May 01, 2017 Filed Jun 16, 2017 10:38 UTC GrantStock Option (right to buy) · Derivative 60,000 $0.40 Strike: $0.40 $24,000.00
Disclosure

SEC source: 0001638599-17-000598 · doc4_4795.xml · derivative · entry 1

GENERAL HILL (Ret) JAMES T. · CIK 0001441718 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 550,000

Underlying: Common Stock · 60,000 shares

Expires 2027-05-01

F1 · derivative.exercise_date: Vests in equal annual installments over three years beginning 12/1/16.

Read SEC document
May 01, 2017 Filed Jun 16, 2017 15:14 UTC GrantStock Option (right to buy) · Derivative 300,000 $0.40 Strike: $0.40 $120,000.00
Disclosure

SEC source: 0001638599-17-000611 · doc4_4801.xml · derivative · entry 1

ERWIN ROBERT L · CIK 0001213822 · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,350,000

Underlying: Common Stock · 300,000 shares

Expires 2027-05-01

F1 · derivative.exercise_date: Vests in equal annual installments over three years beginning 12/1/16.

Read SEC document
May 01, 2017 Filed Jun 16, 2017 15:07 UTC
Kay RobertDirector · Executive Chairman and CEO
GrantStock Option (right to buy) · Derivative 300,000 $0.40 Strike: $0.40 $120,000.00
Disclosure

SEC source: 0001638599-17-000609 · doc4_4800.xml · derivative · entry 1

Kay Robert · CIK 0001285612 · Director · Executive Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,350,000

Underlying: Common Stock · 300,000 shares

Expires 2027-05-01

F1 · derivative.exercise_date: Vests in equal annual installments over three years beginning 12/1/16.

Read SEC document
May 01, 2017 Filed Jun 16, 2017 14:58 UTC
FLUG SEYMOURDirector
GrantStock Option (right to buy) · Derivative 60,000 $0.40 Strike: $0.40 $24,000.00
Disclosure

SEC source: 0001638599-17-000606 · doc4_4799.xml · derivative · entry 1

FLUG SEYMOUR · CIK 0001216262 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 340,000

Underlying: Common Stock · 60,000 shares

Expires 2027-05-01

F1 · derivative.exercise_date: Vests in equal annual installments over three years beginning 12/1/16.

Read SEC document
May 01, 2017 Filed Jun 16, 2017 14:53 UTC GrantStock Option (right to buy) · Derivative 60,000 $0.40 Strike: $0.40 $24,000.00
Disclosure

SEC source: 0001638599-17-000604 · doc4_4798.xml · derivative · entry 1

Elliott Arthur Y · CIK 0001506688 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 460,000

Underlying: Common Stock · 60,000 shares

Expires 2027-05-01

F1 · derivative.exercise_date: Vests in equal annual installments over three years beginning 12/1/16.

Read SEC document
May 01, 2017 Filed Jun 16, 2017 14:32 UTC
Chang GlennDirector
GrantStock Option (right to buy) · Derivative 60,000 $0.40 Strike: $0.40 $24,000.00
Disclosure

SEC source: 0001638599-17-000596 · doc4_4794.xml · derivative · entry 1

Chang Glenn · CIK 0001384967 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 550,000

Underlying: Common Stock · 60,000 shares

Expires 2027-05-01

F1 · derivative.exercise_date: Vests in equal annual installments over three years beginning 12/1/16.

Read SEC document
February 23, 2017 Filed Feb 27, 2017 20:39 UTC PurchasePreferred Stock 1 Not disclosed Not disclosed
Disclosure

SEC source: 0001408408-17-000013 · ecl-ibio02232017.xml · nonDerivative · entry 1

DART KENNETH BRYAN · CIK 0001331271 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By Company

Disclosed balance after: 1

F1 · security: On February 23, 2017, an entity indirectly owned 100% by Kenneth B. Dart ("the Affiliate") acquired one (1) share of the Issuer's Preferred Stock designated as iBio CMO Preferred Tracking Stock with a par value of $0.001 per share (the "Preferred Stock") in exchange for 29,990,000 units of limited liability company interests of iBio CMO LLC ("Units") held by the Affiliate. iBio CMO LLC is a subsidiary of the Issuer. The shares of the Preferred Stock are exchangeable for Units only after March 31, 2018 ("Mandatory Exchange"), or an event which triggers a change of control of iBio CMO LLC, or in connection with a winding up, liquidation or deemed liquidation (such as a merger) of the Issuer or iBio CMO. The Preferred Stock is not convertible into or exchangeable for any of the Issuer's securities. The Preferred Stock has no voting rights with respect to the Issuer.

F1 · kind: On February 23, 2017, an entity indirectly owned 100% by Kenneth B. Dart ("the Affiliate") acquired one (1) share of the Issuer's Preferred Stock designated as iBio CMO Preferred Tracking Stock with a par value of $0.001 per share (the "Preferred Stock") in exchange for 29,990,000 units of limited liability company interests of iBio CMO LLC ("Units") held by the Affiliate. iBio CMO LLC is a subsidiary of the Issuer. The shares of the Preferred Stock are exchangeable for Units only after March 31, 2018 ("Mandatory Exchange"), or an event which triggers a change of control of iBio CMO LLC, or in connection with a winding up, liquidation or deemed liquidation (such as a merger) of the Issuer or iBio CMO. The Preferred Stock is not convertible into or exchangeable for any of the Issuer's securities. The Preferred Stock has no voting rights with respect to the Issuer.

F1 · price: On February 23, 2017, an entity indirectly owned 100% by Kenneth B. Dart ("the Affiliate") acquired one (1) share of the Issuer's Preferred Stock designated as iBio CMO Preferred Tracking Stock with a par value of $0.001 per share (the "Preferred Stock") in exchange for 29,990,000 units of limited liability company interests of iBio CMO LLC ("Units") held by the Affiliate. iBio CMO LLC is a subsidiary of the Issuer. The shares of the Preferred Stock are exchangeable for Units only after March 31, 2018 ("Mandatory Exchange"), or an event which triggers a change of control of iBio CMO LLC, or in connection with a winding up, liquidation or deemed liquidation (such as a merger) of the Issuer or iBio CMO. The Preferred Stock is not convertible into or exchangeable for any of the Issuer's securities. The Preferred Stock has no voting rights with respect to the Issuer.

F1 · ownership.nature: On February 23, 2017, an entity indirectly owned 100% by Kenneth B. Dart ("the Affiliate") acquired one (1) share of the Issuer's Preferred Stock designated as iBio CMO Preferred Tracking Stock with a par value of $0.001 per share (the "Preferred Stock") in exchange for 29,990,000 units of limited liability company interests of iBio CMO LLC ("Units") held by the Affiliate. iBio CMO LLC is a subsidiary of the Issuer. The shares of the Preferred Stock are exchangeable for Units only after March 31, 2018 ("Mandatory Exchange"), or an event which triggers a change of control of iBio CMO LLC, or in connection with a winding up, liquidation or deemed liquidation (such as a merger) of the Issuer or iBio CMO. The Preferred Stock is not convertible into or exchangeable for any of the Issuer's securities. The Preferred Stock has no voting rights with respect to the Issuer.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.